You are here

  • Home
  • Archive
  • Volume 31, Issue 8
  • Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

Article metrics

Article menu
Download PDFPDF
Clinical trial
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

 

Online download statistics by month:

Online download statistics by month: June 2021 to March 2023

AbstractFullPdf
Jun 2021523514
Jul 202140149
Aug 2021382815
Sep 2021201610
Oct 202114299
Nov 202122273
Dec 20211091310
Jan 2022171114
Feb 202216584
Mar 2022165117
Apr 202216992
May 202215021
Jun 2022257113
Jul 202219281
Aug 202216394
Sep 202223491
Oct 202215441
Nov 202213572
Dec 20229452
Jan 20238461
Feb 202310642
Mar 20235350
Total2915231105